PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, FHU CARE, 78 Avenue du general Leclerc, 94270, Le Kremlin-Bicêtre, France. samuel.bitoun@aphp.fr.\', \'Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, Le Kremlin-Bicêtre, France. samuel.bitoun@aphp.fr.\', \'Rheumatology Department, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, FHU CARE, 78 Avenue du general Leclerc, 94270, Le Kremlin-Bicêtre, France.\', \'Virology Department, Université Paris-Saclay, INSERM U1193, AP-HP, Hôpital Paul Brousse, Villejuif, France.\', \'Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, Le Kremlin-Bicêtre, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13045-021-01183-2
?:hasPublicationType
?:journal
  • Journal of hematology & oncology
is ?:pmid of
?:pmid
?:pmid
  • 34645504
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all